title: [The use of sulprostone (Nalador) in the evacuation of uterine contents. Apropos of 32 cases at the Department of Gynecology, University Hospital Center, Nîmes, over 2 years (a retrospective study)].
abstract: We have studied the use of sulprostone in evacuating uterine contents in 32 patients, the majority of whom were in the second trimester of their pregnancies. There are three ways to administer the drug (continuous intravenous, intermittent intravenous, and intramuscular); the best results were obtained when the drug was administered continuously intravenously. It was well tolerated, the use of Nalbuphine reducing pain. There were few side effects. The use of this product is discussed in connection with a few of the cases as well as the possible alternative treatments in difficult cases.
authors.affiliation: Service de Gynécologie-Obstétrique, CHU Carémeau, Nîmes.
authors.forename: C
authors.initials: C
authors.lastname: Marsollier
authors.forename: M L
authors.initials: ML
authors.lastname: Tailland
authors.forename: C
authors.initials: C
authors.lastname: Courtieu
authors.forename: H
authors.initials: H
authors.lastname: Déchaud
authors.forename: P
authors.initials: P
authors.lastname: Marès
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D002921:Cicatrix / Q000150:complications; D000075202:Contraindications; D015232:Dinoprostone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004361:Drug Tolerance; D005260:Female; D005602:France; D005865:Gestational Age; D006801:Humans; D006828:Hydatidiform Mole / Q000175:diagnosis; D007262:Infusions, Intravenous; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D015735:Mifepristone / Q000008:administration & dosage; D016595:Misoprostol / Q000008:administration & dosage; D006831:Polyhydramnios / Q000175:diagnosis; D011247:Pregnancy; D012189:Retrospective Studies; D013997:Time Factors; D014591:Uterine Diseases / Q000150:complications; D014594:Uterine Neoplasms / Q000175:diagnosis
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol; D015735:Mifepristone; C016767:sulprostone; D015232:Dinoprostone
vernacular_title: Utilisation du sulprostone (Nalador) dans l'évacuation du contenu utérin. A propos de 32 observations du Service de Gynécologie CHU Nîmes sur deux années (étude rétrospective).